Health
Johnson & Johnson COVID-19 vaccine linked to potentially paralysing Guillain-Barré syndrome – 7NEWS.com.au
Just weeks ago, the TGA granted the vaccine provisional approval for use in Australia.
There are fears some recipients of Johnson & Johnsons coronavirus vaccine face an increased risk of a rare neurological complication known as Guillain-Barre syndrome (GBS) after an increase in reports of the sometimes paralysing condition.
The US Food and…
Continue Reading
-
Noosa News10 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business15 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business15 hours agoWhere will Nvidia stock be in 1 year?
-
Noosa News14 hours agoStar’s Brisbane casino has been in the headlines for months: What’s the latest?